StockNews.com Begins Coverage on aTyr Pharma (NASDAQ:LIFE)

StockNews.com assumed coverage on shares of aTyr Pharma (NASDAQ:LIFE – Get Rating) in a report published on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Several other equities analysts have also weighed in on the company. Roth Capital reissued a buy rating on shares of aTyr Pharma in a report on […]

Related Keywords

Canada ,San Diego ,California ,United States ,Roth Mkm ,Piper Sandler ,Paul Schimmel ,Atyr Pharma Inc ,Virtu Financial ,Charles Schwab Investment Management Inc ,Squarepoint Ops ,Royal Bank ,Tyr Pharma Company Profile ,Securities Exchange Commission ,Marshall Wace ,Tyr Pharma ,Get Rating ,Moderate Buy ,Director Paul Schimmel ,Exchange Commission ,Street Group ,Charles Schwab Investment Management ,Schwab Investment Management ,Tyr Pharma Company ,Xiang Lei Yang ,Bruce Beutler ,Tyr Pharma Daily ,Atyr Pharma ,Nasdaq Life ,Life ,Medical ,53217v10 ,Initiated Coverage ,Stocknews Com ,